Your browser doesn't support javascript.
loading
IFNγ-IL-17+ CD8 T cells contribute to immunosuppression and tumor progression in human hepatocellular carcinoma.
Lee, Yun Hua; Chuah, Samuel; Nguyen, Phuong H D; Lim, Chun Jye; Lai, Hannah L H; Wasser, Martin; Chua, Camillus; Lim, Tony K H; Leow, Wei Qiang; Loh, Tracy Jiezhen; Wan, Wei Keat; Pang, Yin Huei; Soon, Gwyneth; Cheow, Peng Chung; Kam, Juinn Huar; Iyer, Shridhar; Kow, Alfred; Bonney, Glenn K; Chan, Chung Yip; Chung, Alexander; Goh, Brian K P; Zhai, Weiwei; Chow, Pierce K H; Albani, Salvatore; Liu, Haiyan; Chew, Valerie.
Afiliação
  • Lee YH; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Chuah S; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Nguyen PHD; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Lim CJ; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Lai HLH; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore.
  • Wasser M; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Chua C; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Lim TKH; Department of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
  • Leow WQ; Department of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
  • Loh TJ; Department of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
  • Wan WK; Department of Anatomical Pathology, Singapore General Hospital, Singapore, 169856, Singapore.
  • Pang YH; Department of Pathology, National University Hospital Singapore, 119074, Singapore.
  • Soon G; Department of Pathology, National University Hospital Singapore, 119074, Singapore.
  • Cheow PC; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Kam JH; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Iyer S; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, University Surgical Cluster, National University Health System, Singapore, 119074, Singapore.
  • Kow A; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, University Surgical Cluster, National University Health System, Singapore, 119074, Singapore.
  • Bonney GK; Division of Hepatobiliary & Pancreatic Surgery, Department of Surgery, University Surgical Cluster, National University Health System, Singapore, 119074, Singapore.
  • Chan CY; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Chung A; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Goh BKP; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Zhai W; Genome Institute of Singapore (GIS), Agency for Science, Technology and Research (A*STAR), Singapore, 138672, Singapore; Key Laboratory of Zoological Systematics and Evolution, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100107, China; Center for Excellence in Animal Evolution and Ge
  • Chow PKH; Department of Hepatopancreatobiliary and Transplant Surgery, Division of Surgery and Surgical Oncology, Singapore General Hospital and National Cancer Centre Singapore, Singapore, 169608, Singapore.
  • Albani S; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore.
  • Liu H; Immunology Programme, Life Sciences Institute, Immunology Translational Research Program and Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117456, Singapore.
  • Chew V; Translational Immunology Institute (TII), SingHealth-DukeNUS Academic Medical Centre, Singapore, 169856, Singapore. Electronic address: valerie.chew@duke-nus.edu.sg.
Cancer Lett ; 552: 215977, 2023 01 01.
Article em En | MEDLINE | ID: mdl-36279983
ABSTRACT
IL-17-producing CD8 (Tc17) T cells have been shown to play an important role in infection and chronic inflammation, however their implications in hepatocellular carcinoma (HCC) remain elusive. In this study, we performed cytometry by time-of-flight (CyTOF) and revealed the distinctive immunological phenotypes of two IFNγ+ and IFNγ- Tc17 subsets that were preferentially enriched in human HCC. Single-cell RNA-sequencing analysis further revealed regulatory circuits governing the different phenotypes of these Tc17 subsets. In particular, we discovered that IFNγ- Tc17 subset demonstrated pro-tumoral characteristics and expressed higher levels of CCL20. This corresponded to increased tumor infiltration of T regulatory cells (Treg) validated by immunohistochemistry in another independent HCC cohort, demonstrating the immunosuppressive functions of IFNγ- Tc17 subset. Most importantly, higher intra-tumoral proportions of IFNγ- Tc17 were associated with poorer prognosis in patients with HCC and this was further validated in The Cancer Genome Atlas (TCGA) HCC cohort. Taken together, this compendium of transcriptomic and proteomic data of Tc17 subsets sheds light on the immunosuppressive phenotypes of IFNγ- Tc17 and its implications in HCC progression.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Tolerância Imunológica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Tolerância Imunológica / Neoplasias Hepáticas Idioma: En Ano de publicação: 2023 Tipo de documento: Article